| Identification | Back Directory | [Name]
amyrin palmitate | [CAS]
5973-06-8 | [Synonyms]
Balanophorin A
β-Amyrin palmitate
e-Amyrin palpitate
β-Amyrin 3-palmitate
beta-amyrin palmitate
Oleana-12-ene-3β-ol palmitate
Olean-12-en-3β-ol hexadecanoate
5α-Oleana-12-ene-3β-ol hexadecanoate
Olean-12-en-3-ol,3-hexadecanoate, (3b)-
Olean-12-en-3-ol, 3-hexadecanoate, (3β)-
Hexadecanoic acid oleana-12-ene-3β-yl ester | [Molecular Formula]
C46H80O2 | [MOL File]
5973-06-8.mol | [Molecular Weight]
665.14 |
| Hazard Information | Back Directory | [Description]
Beta-Amyrin palmitate may release norepinephrine from newly synthesized pools, and thus, it may activate noradrenergic activity.
Beta-Amyrin palmitate, like mianserin and imipramine, reduces the duration of immobility of mice significantly in a dose-dependent manner (5, 10 and 20 mg kg-1);
(1)Beta-Amyrin palmitate or mianserin elicits a dose-related reduction in locomotor activity of mice and antagonizes locomotor stimulation induced by methamphetamine, imipramine increases locomotor activity and potentiates methamphetamine-induced hyperactivity;
(2)Beta-Amyrin palmitate shows no effect on reserpine-induced hypothermia, whilst mianserin (10 mg kg-1) and imipramine (10 and 20 mg kg-1) antagonizes the reserpine-induced effect;
(3)Beta-amyrin palmitate has similar properties in some respects to mianserin and might possess a sedative action. | [target]
LDL | HMG-CoA Reductase | Adrenergic Receptor |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|